FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Strides Pharma Testosterone Gel 1% Recall

Testosterone Gel 1%, 2

Strides Pharma, Inc. · Chestnut Ridge, NY

Risk level
Class II
Reported by FDA
Apr 2, 2025
Recall ID
D-0293-2025
Check your lot numberHow we source this data

Summary

Strides Pharma recalled Testosterone Gel 1% starting Mar 5, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0293-2025 on Apr 2, 2025. Reason: Presence of foreign substance: Presence of Benzene. Status: Ongoing.

Why it was recalled

Presence of foreign substance: Presence of Benzene.

Product description

Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-151-02

Lot numbers, UPCs & expiration codes

Lot #: 5501127A, 5501236A, Exp Apr-25; 5501341A, Exp Jun-25; 5501406A, Exp Jul-25; 5501408A, Exp Aug-25; 5501516A, Exp Sep-25; 5501568A, Exp Oct-25; 5501829A, Exp Mar-26; 5502000A, Exp Jul-26; 5502004A, 5502005A, Exp Aug-26; 5502092A, Exp Oct-26; 5502217A, Exp Dec-26; 5502262A, Exp Jan-27

Where it was sold

Nationwide in the U.S

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0293-2025
Classification
Class II
Status
Ongoing
Recall initiated
Mar 5, 2025
FDA report date
Apr 2, 2025
Quantity
195,952 Cartons; 30 sachets/Carton.
Recall type
Voluntary: Firm initiated
Recalling firm
Strides Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0293-2025, exactly as published.

Show all FDA fields
City
Chestnut Ridge
State
NY
Status
Ongoing
Country
United States
Event ID
96412
Address
1 Ram Ridge Rd
Code information
Lot #: 5501127A, 5501236A, Exp Apr-25; 5501341A, Exp Jun-25; 5501406A, Exp Jul-25; 5501408A, Exp Aug-25; 5501516A, Exp Sep-25; 5501568A, Exp Oct-25; 5501829A, Exp Mar-26; 5502000A, Exp Jul-26; 5502004A, 5502005A, Exp Aug-26; 5502092A, Exp Oct-26; 5502217A, Exp Dec-26; 5502262A, Exp Jan-27
Postal code
10977-6714
Report date
Apr 2, 2025
Product type
Drugs
Recall number
D-0293-2025
Classification
Class II
Recalling firm
Strides Pharma, Inc.
Product quantity
195,952 Cartons; 30 sachets/Carton.
Reason for recall
Presence of foreign substance: Presence of Benzene.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-151-02
Distribution pattern
Nationwide in the U.S
Recall initiation date
Mar 5, 2025
Initial firm notification
Letter
Center classification date
Mar 25, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0293-2025, published Apr 2, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls